Health Care Headaches

Affordability and the cost of living have become frequent topics of conversation. Costs rose, but incomes did not immediately keep pace. The rate of inflation has moderated, but consumers remain sensitive to high prices, worried they are falling behind. Higher prices occur when demand exceeds supply, and level off when balance is restored. Many of the latest inflationary challenges are in sectors where equilibrium will be difficult to reach.

Healthcare is one of them. The sector is suffering from a chronic malady of rising costs. Demand for health treatments will never abate; illness, injury and aging are simply parts of the human experience. However, the capacity of the U.S. healthcare system is not keeping pace with the aging population and innovative treatments. Growing demand and limited supply lead to higher prices.

Of late, costs are on the rise as novel therapies come to market for more specific illnesses. Breakthroughs in gene therapy and cancer treatments are tremendous advancements, but their high development costs are spread across fewer patients. GLP-1 drugs offer promising outcomes for a growing array of symptoms, but insurers are hesitant to cover the high price of using them for non-critical applications.